Dream Eye
- Manufacturer
- K&J.C Co., Ltd
- Effective date
- 2010-10-13
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:26:15
Label at a glance#
ProductDream Eye
Active ingredientPOLOXAMER 407
Label structure11 sections
Label contents#
Full prescribing information#
Active Ingredient: Poloxamer 407
DESCRIPTION SECTION
STEP 1:
Place 3 drops of Dream Eye on each side of contact lens and rub for 20 seconds. No
necessary. separate daily cleaner
STEP 2:
Remove surface debris by rinsing thoroughly with Dream Eye
STEP 3:
Place cleaned contact lens in the lens case and fill with fresh Dream Eye MPS. Soak at
least four(4) hours.
Place 3 drops of Dream Eye on each side of contact lens and rub for 20 seconds. No
necessary. separate daily cleaner
STEP 2:
Remove surface debris by rinsing thoroughly with Dream Eye
STEP 3:
Place cleaned contact lens in the lens case and fill with fresh Dream Eye MPS. Soak at
least four(4) hours.
OTC - WHEN USING SECTION
Cleans, loosens and removes accumulations of film, deposits and debris from
soft contact lenses. Destroys harmful micro-organisms on the surface of the
lens. Rinse, stores and rewets lenses before insertion. For dissolving of
Enzymatic Contact Lens Cleaner tablets for removal of protein deposits.
soft contact lenses. Destroys harmful micro-organisms on the surface of the
lens. Rinse, stores and rewets lenses before insertion. For dissolving of
Enzymatic Contact Lens Cleaner tablets for removal of protein deposits.
PRECAUTIONS SECTION
PRECAUTIONS:
☞ Never re-use this solution.
☞ Keep the bottle tightly closed when not in use.
☞ Store at room temperature.
☞ Use before the expiration date marked on the bottle and carton.
☞ Never re-use this solution.
☞ Keep the bottle tightly closed when not in use.
☞ Store at room temperature.
☞ Use before the expiration date marked on the bottle and carton.
OTC - PURPOSE SECTION
ACTIONS: Cleans, loosens and removes accumulations of film, deposits and debris from
soft contact lenses. Destroys harmful micro-organisms on the surface of the
lens. Rinse, stores and rewets lenses before insertion. For dissolving of
Enzymatic Contact Lens Cleaner tablets for removal of protein deposits.
soft contact lenses. Destroys harmful micro-organisms on the surface of the
lens. Rinse, stores and rewets lenses before insertion. For dissolving of
Enzymatic Contact Lens Cleaner tablets for removal of protein deposits.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of the reach of children
INDICATIONS & USAGE SECTION
INDICATIONS(Uses): Dream Eye is indicated for use in daily cleaning,
dissolving of Enzymatic Contact Lens Cleaner tablets, rinsing and storage of daily
and extended wear soft contact lenses and chemical (not heat)
disinfection, as recommended by your eye care professional.
dissolving of Enzymatic Contact Lens Cleaner tablets, rinsing and storage of daily
and extended wear soft contact lenses and chemical (not heat)
disinfection, as recommended by your eye care professional.
WARNINGS SECTION
WARNING: PROBLEMS WITH CONTACT LENSES AND LENS CARE PRODUCTS COULD
RESULT IN SERIOUS INJURY TO THE EYE. It is essential that you follow your
eye care practitioner's directions and all labeling instructions for proper use
and care of your lenses and lens care products, including the lens case.
☞ To avoid contamination, do not touch tip of container to any surface. Replace cap
after using.
☞ Not intended for use directly in the eye.
☞ Not for use with heat(thermal) disinfection.
RESULT IN SERIOUS INJURY TO THE EYE. It is essential that you follow your
eye care practitioner's directions and all labeling instructions for proper use
and care of your lenses and lens care products, including the lens case.
☞ To avoid contamination, do not touch tip of container to any surface. Replace cap
after using.
☞ Not intended for use directly in the eye.
☞ Not for use with heat(thermal) disinfection.
DOSAGE & ADMINISTRATION SECTION
DIRECTIONS:
☞ After removing the lens, place it in the palm of your hand, and place three drops of
Daily Cleaner on each lens surface. or Soak at least four(4) hours in Dream Eye.
☞ Rub the lens for 20 seconds either in the palm of your hand using the forefinger
of the other hand, or between the thumb and forefinger. Be sure to clean each side
of the lens.
☞ Rinse the lens thoroughly by holding the lens in a steady stream of saline solution
for approximately 10 seconds.
☞ Disinfect using the procedure which your practitioner has recommended.
☞ After removing the lens, place it in the palm of your hand, and place three drops of
Daily Cleaner on each lens surface. or Soak at least four(4) hours in Dream Eye.
☞ Rub the lens for 20 seconds either in the palm of your hand using the forefinger
of the other hand, or between the thumb and forefinger. Be sure to clean each side
of the lens.
☞ Rinse the lens thoroughly by holding the lens in a steady stream of saline solution
for approximately 10 seconds.
☞ Disinfect using the procedure which your practitioner has recommended.
INACTIVE INGREDIENT SECTION
Inactive ingredient: Sodium Chloride, Sodium Borate, Boric Acid, HYPROMELLOSES, EDETATE DISODIUM, Water
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 52345-3001-1 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c335-8e05-e053-dbdaa90a074a | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52345-3001-1 | Dream Eye | 40 mL in 1 BOTTLE, PLASTIC | LIQUID | 40 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 52345-3001 | DREAM EYE (POLOXAMER 407) LIQUID [K&J.C CO., LTD] | 1 | Legacy NDC, 1 package rows | 20101102_24289372-0787-4a28-82d9-d136273d0667.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| POLOXAMER 407 | ACTIVE INGREDIENT | TUF2IVW3M2 | 1 | |
| POLOXAMER 407 | ACTIVE MOIETY | TUF2IVW3M2 | 1 | |
| BORIC ACID | INACTIVE INGREDIENT | R57ZHV85D4 | 1 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | 1 | |
| SODIUM BORATE | INACTIVE INGREDIENT | 91MBZ8H3QO | 1 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- Dream Eye
- POLOXAMER 407
- SODIUM CHLORIDE
- SODIUM BORATE
- BORIC ACID
- HYPROMELLOSES
- EDETATE DISODIUM
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 52345-3001 | 52345-3001-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| POLOXAMER 407 | TUF2IVW3M2 | ACTIB |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| SODIUM BORATE | 91MBZ8H3QO | IACT |
| BORIC ACID | R57ZHV85D4 | IACT |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| WATER | 059QF0KO0R | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | EMULSION / TOPICAL | 0.11 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 0.4 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | GEL / OPHTHALMIC | 0.9 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SHAMPOO / TOPICAL | 1 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRATHECAL | 131 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, DELAYED RELEASE / ORAL | 79 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / SUBCUTANEOUS | 6 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUPPOSITORY / RECTAL | 140 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRA-ARTICULAR | 26 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / EPIDURAL | 0.9 %w/v | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | JELLY / VAGINAL | 1 %w/w | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | GEL / RECTAL | 348 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRAVESICAL | 351 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / AURICULAR (OTIC) | 0.01 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, ORALLY DISINTEGRATING / ORAL | 10 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 0.68 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRALESIONAL | 0.05 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRAMUSCULAR | 1486 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAPERITONEAL | 226 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | JELLY / TOPICAL | NA | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / RESPIRATORY (INHALATION) | 0.01 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / ORAL | 148 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, ORALLY DISINTEGRATING / ORAL | 3 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRA-ARTERIAL | 278 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAPERITONEAL | 0.54 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 2922 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / PERINEURAL | 648 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS | 0.86 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRALESIONAL | 13 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / SUBMUCOSAL | 17 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | EMULSION / OPHTHALMIC | 0.3 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, EXTENDED RELEASE / ORAL | 10 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / TOPICAL | 210 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SUSPENSION / INTRA-ARTICULAR | 45 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, FILM COATED / ORAL | 4 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, CHEWABLE / ORAL | 1 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / PARENTERAL | 584 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / ENDOTRACHEAL | 7.6 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / ENDOTRACHEAL | 68 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / RESPIRATORY (INHALATION) | 108 mg | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | SOLUTION / AURICULAR (OTIC) | 0.05 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CREAM / VAGINAL | 3 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | GRANULE, FOR SUSPENSION / ORAL | 1.7 mg | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | EMULSION / TOPICAL | 1.3 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SPRAY / NASAL | 30 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CREAM / TOPICAL | 0.1 %w/w | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 221 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, EXTENDED RELEASE / ORAL | 119.7 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SYRUP / ORAL | 40 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / RECTAL | 97 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRABURSAL | 9 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SOLUTION / INTRAMUSCULAR | 4 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LOTION / TOPICAL | 0.3 %w/v | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | INJECTION, SOLUTION / INTRAVENOUS | 210 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | AEROSOL, FOAM / TOPICAL | 0.05 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SUSPENSION / SOFT TISSUE | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / INTRAVENOUS | 0.05 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, CHEWABLE / ORAL | 20 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LIQUID / NASAL | 2 mg/1ml |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| afdb9a19-6514-4467-b2b9-ff809dc565e7 | 24289372-0787-4a28-82d9-d136273d0667 | 2010-10-13 | Warnings | afdb9a19-6514-4467-b2b9-ff809dc565e7 24289372-0787-4a28-82d9-d136273d0667 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
